Amrita Singh Chandhoke

机构：University of Calgary, Dana-Farber Cancer Institute, Discovery Laboratories (United States), FogPharma (United States)

发表论文 11 篇 · 总被引 316 次 · h-index 8

代表论文

• Defining and Targeting Adaptations to Oncogenic KRASG12C Inhibition Using Quantitative Temporal Proteomics (2020 · Cell Reports · 被引 83)
• The ubiquitin ligase Smurf2 suppresses TGFβ-induced epithelial–mesenchymal transition in a sumoylation-regulated manner (2015 · Cell Death and Differentiation · 被引 75)
• The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness (2017 · Oncotarget · 被引 38)
• TIF1γ Protein Regulates Epithelial-Mesenchymal Transition by Operating as a Small Ubiquitin-like Modifier (SUMO) E3 Ligase for the Transcriptional Regulator SnoN1 (2014 · Journal of Biological Chemistry · 被引 34)
• A novel role for the SUMO E3 ligase PIAS1 in cancer metastasis (2014 · Oncoscience · 被引 34)
• Identification of a Novel Link between the Protein Kinase NDR1 and TGFβ Signaling in Epithelial Cells (2013 · PLoS ONE · 被引 23)